Jyothy Labs (532926) Q2 24/25 earnings summary

Executive summary

• Q2 FY25 consolidated revenue reached INR 734 crores (₹73,376 lacs), up 0.2% year-over-year, with 3% volume growth and PAT at INR 105 crores (₹10,502 lacs), a 1% increase year-over-year.

• Rural demand improved, e-commerce and quick commerce channels saw robust growth, and new campaigns and celebrity endorsements supported brand investments.

• Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2024, with no material misstatements identified by auditors.

• H1 FY25 revenue grew 4% year-over-year to INR 1,476 crores (₹1,47,557 lacs), with PAT up 3.2% to INR 206.7 crores (₹20,671 lacs).

• Brand focus included expanding product lines, distribution, and consumer engagement initiatives.

Financial highlights

• Gross margin for Q2 FY25 was 50.2%, up from 49.2% year-over-year; H1 FY25 gross margin was 50.7%.

• Operating EBITDA margin for Q2 FY25 was 18.9% (vs. 18.5% last year); H1 FY25 EBITDA margin was 18.4%.

• PAT margin for Q2 FY25 was 14.3%, and H1 FY25 was 14.0%.

• Advertising and promotional spend increased to 8.3% of sales in Q2 and H1 FY25.

• Company remains debt-free with cash reserves of INR 659 crores (Rs 658.6 crore) after a dividend payout of INR 128 crores (₹12,852 lacs).

Outlook and guidance

• Margin guidance for FY25 remains at 16%-17% EBITDA, despite achieving 18.5% in H1, due to potential raw material price volatility and planned brand investments.

• Q3 is expected to see mid- to high-single-digit volume growth, with price hikes in soaps and other categories likely in Q4.

• Focus on rural distribution expansion, direct retail presence, premiumization, and operational efficiencies.

• New product launches and entry into new categories are planned for the coming quarters.

• Continued investments in brands, distribution, and cost optimization.